The aim of this study was to evaluate at a population level whether hypertension is a risk factor for cardiovascular mortality and to verify whether or not this is true for both genders at any age. Methods: This population-based, long-lasting, prospective study includes a 14-year mortality (institutional epidemiology in primary care). Unselected, unbiased subjects (5185) aged 22 to 95 years were recruited from the Italian general population, and divided into normotensive (Ͻ140 mm Hg systolic blood pressure [BP] and Ͻ90 mm Hg diastolic BP and untreated) and hypertensive groups. The main aim was to identify the significant predictors of mortality due to stroke, coronary artery disease, heart failure, and pulmonary embolism, and to quantify the age-adjusted relative risk of hypertension in men and women, at different age classes (Ͻ70, 70 to 79, Ն80 years) for each mortality cause. The analysis was repeated among 1091 normotensive and 1091 hypertensive age-matched subjects to clean statistics from the effects of age.
A
rterial hypertension is considered one of the most powerful risk factors, and the general belief is that it increases cardiovascular mortality both in men and women. The Framingham study gave the greatest contribution to this opinion. [1] [2] [3] Although this concept is continuously re-echoed in the literature, the only way to demonstrate a negative prognostic effect of hypertension is represented by the studies based on general population that include hypertensive patients as well as normotensive all-age subjects. In fact, animal studies cannot be directly used for humans for evident reasons, and cohort studies cannot be generalized without introducing biases. And the number of populationbased studies dealing with this topic is limited.
The present study aimed at evaluating 1) whether or not arterial hypertension predicts cardiovascular mortality at a population level; 2) if so, whether or not this is true for both genders and at all ages, and 3) which component of cardiovascular mortality depends on blood pressure (BP) levels.
Methods

Study Population
A cohort of North Italian subjects aged 22 to 95 years were called in a population-based frame with a recruitment procedure only based on the Register Office files; 5185 subjects (ie, 73% of called ones) agreed with the study protocol, gave informed consent, and were recruited, whereas the remaining 27% did not answer or did not accept the study protocol. The subjects included and those not included in the study had similar age and gender distribution (data not shown).
The study lasted 14 years and was carried out in accordance with the Declaration of Helsinki of the World Medical Association, and approved by the local Ethics Com-mittees. The procedures followed were in accordance with institutional guidelines.
Data Collection
A Hypertension Unit consisting of doctors expert in hypertension was activated for this study. Attention was given to assure that BP measurements were not biased by the residual effect of antihypertensive treatment (Fig. 1 ) . Those individuals who were being treated for hypertension (52%) underwent a 4-week wash-out period (representing the best compromise with a realistic development of the study). In such subjects, the beginning of the study was postponed, and the first BP values were taken at the end of this period. As shown in Fig. 1 , the study lasted 168 months (or until death) in all cases. No drop-out was observed during the wash-out phase, due to assiduous observation by the Hypertension Unit and strict cooperation between the Hypertension Unit and the general practitioners.
The schedule of BP measurements is shown in Fig. 1 . Supine BP (Korotkoff phases 1 and 5) was taken eight times in 2 months (in triplicate at 15-min intervals at visit 1 and 2, in duplicate at 15-min intervals at visit 3). To reduce the white-coat effect and the alarm reaction, if any, only the average of the last two of the eight BP measurements was taken into consideration for the analysis of data and for the diagnosis of hypertension (discussed later). Only after visit 3, subjects labeled as hypertensive were free to receive antihypertensive treatment. This was necessary in 707 subjects. Because this is a long-lasting study, periodical controls were scheduled to determine how many subjects developed hypertension during the follow-up and to ascertain whether later antihypertensive treatment was necessary.
Historical data were recorded. All subjects underwent physical, laboratory, and instrumental examination (electrocardiogram, echocardiogram, chest X-ray, spirometry, and myocardial scintigraphy when necessary).
Definitions and Cut-Off Values
Because the definition of "elderly" is uncertain, the median age of the study population (70 years) was considered as the cut-off point. Subjects were labeled as not old when aged less than 70 years; according to the literature, elderly subjects aged 70 years or more were further divided into old and very old (80 years and older). 4 According to current guidelines, 5 subjects were labeled as hypertensive (HT) when at the end of the wash-out phase the systolic BP was Ն140 mm Hg or the diastolic BP was Ն90 mm Hg, and as normotensive (NT) when both systolic and diastolic BP were below these values.
Subjects with one of the following criteria: Minnesota code 6 equal to 1. 7.7 . Subjects having enlarged heart at chest X-ray, dyspnea, or peripheral edema were considered to have congestive heart failure (CHF).
Body mass index (BMI) was calculated as the ratio of weight (in kilograms) to squared height (in meters). Subjects with repeated fasting blood glucose of Ͼ7 mmol/L (126 mg/dL), a history of diabetes, or treatment with antidiabetic drugs were considered to be diabetic. 7 Subjects with total cholesterol of Ͼ5.2 mmol/L (200 mg/dL) were hypercholesterolemic, 8 those with serum triglycerides Ͼ1.7 mmol/L (150 mg/dL) were hypertriglyceridemic. 9 A diagnosis of proteinuria 10 required a urine level of 2 g/L.
Mortality Data
Mortality monitoring was based on the Register Office (which in Italy is very accurate when death is concerned) FIG. 1 . Plan of the study. Solid line) subjects who were untreated for hypertension at the initial screening; dashed line) treated subjects whose inclusion in the study was postponed (wash-out phase). The study lasted 168 months or until death in all subjects.
and double-checked for causes of death by referring to hospitals, retirement homes, or physicians' files. Deaths due to CAD (myocardial infarction or fatal angina pectoris), stroke, CHF, or pulmonary embolism were classified as cardiovascular, the other deaths were labeled as noncardiovascular.
Statistical Analysis
Descriptive Statistics Values of continuous variables were expressed as mean Ϯ standard deviation; 95% confidence intervals (95% CIs) were indicated when appropriate. Analysis of variance with the Bonferroni's correction was used to compare grouped continuous variables, and the Pearson's 2 test to compare the prevalence of categoric variables. Because age, number of men, BMI, blood glucose, serum cholesterol, triglycerides, and uric acid, as well as the prevalence of proteinuria, diabetes, smoking, and history of CAD and stroke, were higher in HT than in NT subjects, grouped BP values were always adjusted for these confounders.
Predictive Role of Hypertension as a Categoric
Item Annual mortality rates were compared with the Kaplan-Mayer approach after generating cumulative survival curves. Multivariate stepwise proportional hazard Cox regression was used to identify the variables having a prognostic role. The categoric variable hypertension was included as a covariate in such analyses.
The analysis was first performed in the entire population, then for each gender separately. All variables were used in multivariate analysis, rather than their interaction; the covariates used to adjust for confounders are specified time to time in the Results section (treatment of hypertension, present or absent, was always included as a covariate). Relative risk (RR) of hypertension was calculated for each mortality.
Predictive Role of BP as a Continuous Item A further
Cox analysis was performed using the continuous variables systolic BP and diastolic BP as covariates, instead of hypertension. The aim of this procedure was to evaluate whether, independent of the label of hypertension, mortality increased with increasing BP. This analysis was performed separately in NT subjects and then in HT patients, to clarify whether the quality of NT guaranteed a protection for any level of BP. Because systolic and diastolic BP were not independent to each other, their natural logarithm was used instead of original values.
Adjustment for Age
The role of hypertension was distinguished from that of age, which was achieved by age adjustment and age matching. Multivariate adjustment for age was obtained by including age as a covariate in all proportional hazard regressions of mortality. Age matching was obtained with the case-by-case method, searching in the entire population for two groups of subjects (NT and HT); each subject of the first group corresponded to someone in the second group with the same age. This way 1091 NT and 1091 age-matched HT subjects were identified. The 2182 matched subjects were obviously obtained with a nonrandom procedure; the experimental cohort created by this operation was nevertheless perfectly acceptable for the aims of the present study, having general characteristics comparable to those of the entire population apart from BP (Table 1) . 
Results
General Characteristics of the Population
The general characteristics of the study population are summarized in Table 1 . Mean age was 61.6 Ϯ 17.9 years (range, 22 to 95 years), median age 70 years; 2932 subjects (1541 men and 1391 women) were not old, 1859 (1135 and 724, respectively) old, and 394 (274 and 120, respectively) very old; 1487 were NT and 3698 HT. The general characteristics of the NT and HT subjects are shown in Table 2 .
The BP values by age classes are shown in Fig. 2 . Prevalence of hypertension was 57.2% in the not old, 86.5% in the old (P Ͻ .0001 v not old), and 85% in the very old subjects (P Ͻ .0001 v not old, insignificant difference versus old). Rates are summarized in Table 3 . At univariate analysis, mortality due to stroke, CAD, and CHF was apparently higher, both in men and women, in HT than in NT subjects (P Ͻ .01). The same trend was observed for noncardiovascular mortality, suggesting a nonspecific (noncardiovascular) trend probably attributable to the difference in age of the two categories of subjects (48. 
Analysis of Mortality Corrected for the Effects of Age
The correction for the effects of age was performed by age adjustment and age matching. These two methods gave concordant results.
Age Adjustment
The multivariate RR of hypertension, calculated after adjusting for age, are shown in Fig. 3 . When the entire population was taken into account (top panel), arterial hypertension had a prognostic role only for stroke mortality (RR 1.40, 95% CI 1.01-2.3), whereas CAD and CHF mortality were not predicted by hypertension.
A subsequent gender-specific analysis (middle and bottom panels) showed that the effect of arterial hypertension on stroke mortality was only present in women (RR 1.90, 95% CI 1.02-4.12); in men no prediction of mortality by the label of hypertension was possible.
Age Matching To confirm once more that the results of univariate analysis were influenced by age, a cohort of 2182 subjects case-to-case matched for age and gender NT ϭ normotensive; HT ϭ hypertensive.
was selected (among the matched subjects, prevalence of hypertension was by definition 50%, ie, lower than in the entire study population, and BP values were consequently lower, but as previously mentioned, the other characteristics were comparable; see Table 1 ). In this experimental matched cohort there were 556 deaths (14-year rate 25.5%); 252 of them were cardiovascular (52 due to stroke, 76 to CAD, 111 to CHF, and 13 to pulmonary embolism). Rates are shown in Table 3 . Only stroke mortality was significantly higher in HT than in NT matched subjects, and only in women (RR of hypertension 2.57 95% CI 1.04 -6.36). Also in this cohort, no prediction of mortality was possible for men, either based on the label of hypertension or on BP values.
Mortality Model in Women
Apart from hypertension, four other items were multivariate predictors of stroke mortality in women, namely atrial fibrillation (RR 3.35, 95% CI 1.93-5.80), diabetes (RR 1.86, 95% CI 1.28 -2.70), history of stroke (RR 2.61, 95% CI 1.54 -4.43), and history of CAD (RR 1.46, 95% CI 1.01-2.25). Other independent variables such as hypercholesterolemia, hypertriglyceridemia, smoking habit, BMI, proteinuria, heart rate, intermittent claudication, coffee and alcohol consumption, atrioventricular block, left bundle branch block, left anterior hemiblock, and antihypertensive treatment did not reach statistical significance (ie, did not play any prognostic role). Values of multivariate 2 and probability of each significant covariate are summarized in Table 4 .
When systolic and diastolic BP were used as continuous variables, separately, among NT women and then among HT women, they had a role only in HT women. Among HT women, the Cox coefficient was positive for systolic (ϩ6.4 Ϯ 2.1, indicating a worsening prognostic role of high systolic BP) and negative for diastolic BP (Ϫ5.6 Ϯ 2.2, indicating a protective effect of a high diastolic BP). After dividing women into classes of age, arterial hypertension predicted stroke mortality in not old and old, but not in very old women (Fig. 4) .
Discussion
Hypertension Predicts Only Stroke Mortality
On the basis of univariate analysis, arterial hypertension appeared to be a predictor of stroke, CAD, and CHF mortality (Table 3) . Apart from stroke, this was only a bias due to age; HT patients were, in fact, older than the NT and therefore more prone to die of cardiovascular disease (as well as of any other cause) than the NT group. After the effect of age was removed with age correction or even better with age matching, only stroke mortality remained significantly and multivariately influenced by hypertension. In the experimental conditions represented by two age-matched groups (in which the between-group effects of age were completely abolished), the risk of stroke mortality was double in HT patients than in NT subjects, whereas those of CAD and CHF were not statistically different in the two groups. Therefore, the present data create the impression that stroke is a direct consequence of hypertension, at least in women, whereas the relationship between hypertension and CAD or between hypertension and CHF, if any, is largely influenced by age. This is not the first notation in this respect, as not all the studies demonstrated a clear contribution of hypertension to development of cardiovascular risk, particularly in the elderly. This is pointed out both by epidemiologic studies and clinical trials.
The Framingham researchers, who notoriously sustain the importance of BP in cardiovascular risk, in a recent reanalysis had to conclude that CAD mortality does not depend on BP in a linearly increasing manner. 11 In the National Health and Nutrition Examination Survey, diastolic and mean BP were not predictive of cardiovascular mortality, 12 and Glynn 13 and Langer 14 -16 and their colleagues even found-in separate studies-a paradoxically higher survival at higher BP, particularly in old and very old subjects. Pekkanen et al, 17 studying 1619 men aged 40 to 59 years at baseline, found that BP was no longer associated with coronary risk after 20 years of follow-up, when the subjects had become old. Finally, Staessen et al 18 found an absence of a relation between CAD events and systolic BP in untreated patients.
Finally, although the intervention trials (obviously including hypertensive patients only) are not a good model for determining the role of hypertension as a predictor, meta-analysis of randomized large-scale trials interestingly indicated that reduction of CAD events in treated hypertensive patients could be lower than expected. 19 A recent meta-analysis of 4233 persons with hypertension even showed an increased risk of events in those in whom the lowest BP was achieved. 20 The Julius' opinion is that " . . . BP lowering does not equally affect all complications of hypertension. Particularly bothersome is the fact that treatment decreases stroke but fails to substantially reduce CAD events. These variations in treatment outcomes may reflect the multifactorial pathophysiology of hypertension: essential hypertension is frequently associated with BP-independent coronary risk factors." 21 Is this sufficient to conclude that the some subjects are immune from hypertension and even protected by high BP values? We do not take a position in this debate.
Role of Gender
Our data clearly show that hypertension had no influence on stroke mortality in men. The reason for this can only be the object of speculation. Women seem to be more prone to cerebral ischemia after nocturnal BP falls 22 and less responsive to stroke prevention with acetylsalicylic acid. 23 Furthermore, women's arrival to the hospital after a stroke is usually delayed in comparison to men, 24 and finally, women probably have a greater incidence of stroke com- plications. 25 Whether or not such characteristics are sufficient to explain the higher stroke mortality observed in women in response to hypertension remains to be clarified.
Role of Advanced Age
Another piece of evidence coming from the present study is that, among women, the weight of high BP on stroke mortality was declining with age (RR of hypertension was 4.78 before 70 years, 3.69 between 70 and 79 years, and 0.37 [insignificant] in women aged 80 years or older).
One possible explanation is that the relative risk of hypertension decreases with increasing age simply because the absolute risk of age increases. The covariate hypertension is overwhelmed (both statistically and biologically) by the more powerful covariate of age. This is probably why many investigators found that the importance of arterial hypertension as a cardiovascular risk factor is less pronounced 20 -26 or even inverted 14, 15 with the advanced age.
Another possible explanation is that elderly persons are the survivors of a population where a significant mortality due to hypertension-related complications has already made its mark, eliminating those having the worst risk pattern or more subjected to experiment lethal consequences of high BP.
BP as a Continuous Variable
As pointed out, the present study demonstrates that the label of HT was predictive of stroke mortality in women. When BP was considered as a continuous variable, systolic BP had a prognostic role on stroke mortality among HT women, with a Cox coefficient of 6.4 Ϯ 2.1 (the higher systolic BP, the greater the stroke mortality). This was not the case in NT women, where no systolic value below 140 mm Hg was dangerous, thus indirectly validating the reliability of this upper limit of BP normalcy.
At variance with systolic BP, the Cox coefficient of diastolic BP was negative in HT women, indicating a worse survival with decreasing diastolic values. Accordingly, many researchers demonstrated that low diastolic BP values, especially when associated with a high systolic BP (high pulse pressure) can increase the risk of stroke 27,28 with a higher incidence of carotid stenosis 29, 30 or a reduction in cerebral flow. 31, 32 The studies of Langer et al 14 and of Benetos et al, 33 showing a higher mortality in treated HT having a prevalent decrease in diastolic BP, are in keeping with this view.
In conclusion, in a population such as that reported in this study arterial hypertension predicts stroke mortality in women but not in men. Coronary artery disease, CHF, or pulmonary embolism mortality is not predicted by hypertension in either men or women. More in details, arterial hypertension predicts stroke mortality only in HT women aged less than 80 years. Stroke mortality increases with increasing BP values in HT women; this does not happen in NT women, where stroke mortality does not increase at any age with increasing BP until the cut-off of 140/90 mm Hg is reached.
